Genscript Biotech Corp (GNNSF)
1.47
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Genscript Biotech Shareholders Equity (Quarterly): 1.391B for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.391B |
| June 30, 2023 | 1.355B |
| June 30, 2023 | 1.355B |
| December 31, 2022 | 1.011B |
| June 30, 2022 | 757.35M |
| June 30, 2022 | 757.35M |
| December 31, 2021 | 1.046B |
| June 30, 2021 | 1.011B |
| June 30, 2021 | 1.011B |
| December 31, 2020 | 1.082B |
| June 30, 2020 | 943.36M |
| June 30, 2020 | 943.36M |
| December 31, 2019 | 382.80M |
| Date | Value |
|---|---|
| June 30, 2019 | 453.90M |
| June 30, 2019 | 453.90M |
| December 31, 2018 | 478.66M |
| June 30, 2018 | 487.75M |
| June 30, 2018 | 487.75M |
| December 31, 2017 | 217.81M |
| June 30, 2017 | 197.28M |
| June 30, 2017 | 197.28M |
| December 31, 2016 | 177.61M |
| June 30, 2016 | 170.32M |
| June 30, 2016 | 170.32M |
| December 31, 2015 | 149.25M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
382.80M
Minimum
Dec 2019
1.391B
Maximum
Dec 2023
930.18M
Average
1.011B
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 762.17M |
| Gracell Biotechnologies Inc (DELISTED) | 222.18M |
| Adagene Inc | 70.56M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.387B |
| Total Liabilities (Quarterly) | 1.343B |
| Debt to Equity Ratio | 0.2474 |
| Current Ratio | 4.756 |
| Net Debt Paydown Yield | -0.95% |